External incubation drives endogenous power The rise of the new forces of Nanjing's minimally invasive medical industry

As one of the seven strategic emerging industries in China, the biopharmaceutical industry has always occupied a very important position, and it is also an important area to influence and change the social economy With the planning and layout of the national-level new district Nanjing Jiangbei New Area, the development of the biopharmaceutical industry in Nanjing has also ushered in a new development situation With Nanjing Biomedicine Valley as the core of the modern biopharmaceutical industry cluster gradually formed, and become the key industry built by Jiangbei New Area Minimally invasive medical is the new blue sea in the biopharmaceutical industry, many entrepreneurial and innovative enterprises into the field, the grand spread of ambition and ambition Under the cultivation and cultivation of Nanjing Biomedicine Valley, a number of powerful enterprises with innovation-driven and scientific research and transformation ability, which are being developed on behalf of the micro-invasive diagnosis and treatment industry, have been born with The Strong Enterprise representing Nanjing Tianrun Yikang as the outstanding representative One-stop service focus on industrial chain optimization Biomedicine Valley into "magnet stone" "annual growth rate of more than 300% sales report", "new three boards' listed during the year", "well-known financial investment institutions push" .. In a short period of three years, some enterprises are still in the initial stage of entrepreneurship, Nanjing Tianrun Yikang has stepped into the fast lane of development Tianyikang is a high-tech enterprise focused on bio-tissue engineering materials and minimally invasive diagnosis and treatment, committed to cutting-edge biotechnology research and development and industrialization, headquartered in Nanjing High-tech District Biomedicine Valley It took only three years from the beginning of the start-up to the deep development In fact, in Nanjing Biopharmaceutical Valley, such as Tianyi Kang such a star enterprise is not in the minority The rapid growth of these enterprises is inextricably linked to the careful incubation and cultivation of the Valley of Medicine Nanjing Biopharmaceutical Valley Planning Map Nanjing Biopharmaceutical Valley since its establishment has been committed to building a comprehensive and perfect one-stop service platform to serve the entire biopharmaceutical industry After several years of development, the platform's cluster advantages continue to be highlighted At present, the biopharmaceutical valley public service platform has become a "magnet stone" to attract enterprises into the drug valley, is the highest technical standards, the most professional service "one-stop" public service platform, for biomedical research and development, enterprise technology innovation and other services, to provide coverage of new drug research and development testing services, information consulting, personnel training, approval declaration and other public services Take Tianyin Yikang as an example, because the location in Nanjing Biomedicine Valley, relying on a full range of integrated service system and excellent resource allocation, the company in the field of medical research encountered difficulties can be easily solved, such as the need for the site only need to provide demand, biomedicine valley can be very quick to provide appropriate solutions Secondly, Nanjing Biopharmaceutical Valley to give enterprises a good and sustainable policy guidance, so that enterprises do better For example, the policy guide to train science and technology entrepreneurs, high-tech enterprises new three board listing success, to give a certain financial incentives; These are not the same as the way in which money is rewarded with a product alone Enterprise development has both internal motivation and government policy guidance, often more easily become excellent enterprises high-tech district leaders came to Tianyi Kang Biological Co , Ltd to inspect the future of the biopharmaceutical industry high-tech zone itself in the integration of the production city planning is particularly good, conducive to attracting outstanding talent to live and work here, and biopharmaceutical valley industry planning is to build a vitality of the biopharmaceutical industry cluster As more enterprises gather, it will cover the upstream and downstream of the industry to form a clear whole industrial chain Each enterprise will have its own core competitiveness, some focus on research and development, some focus on production, some focus on marketing, etc , after the formation of the industrial cluster ecosystem, we can avoid the waste of resource allocation, improve the efficiency of enterprises and society as a whole Capital is the most powerful lever to pry entrepreneurship and innovation, capital can only be combined with science and technology, in order to bear fruit in industry In terms of financial support, high-tech zones guide and support various types of investment institutions to increase investment in park enterprises Since this year, nearly 20 enterprises in the region have received 1.1 billion yuan in external investment, of which Galaxy Capital has invested 680 million yuan in Nanjing High-tech Biopharmaceutical Industry Innovation Center Co., Ltd., focusing on the construction of the model animal global sales channel of Nanjing High-tech Biopharmaceutical Industry Innovation Center, as well as the cancer immunotherapy drug screening and testing platform, the construction of a humanization platform for genetically modified mice, and the industrialization of innovative macromoleculedrugs based on platform development In addition, the world and genes, Paneng power, Tianyikang and a number of park enterprises to obtain external capital pro-gaze With smooth funding channels, good policy guidance, optimized service system and other one-stop comprehensive services, biomedicine valley for more pharmaceutical enterprises to provide excellent entrepreneurial innovation hot land, the minimally invasive medical industry has therefore taken root, to extend the development Continuous innovation drives the focus on scientific research and transformation Of micro-invasive medical enterprises potential development of a good external environment is a stepping stone to enterprise development, but the real vitality of enterprises comes from the internal continuous breakthrough and innovation, especially in the biopharmaceutical industry As a cutting-edge bio-manufacturing industry, the need for technological innovation is more urgent, which requires enterprises to have the quality of research and development manufacturing, excellent innovation, Tianyikang has become a biomedicine valley, precisely because enterprises focus on continuous scientific research innovation and effective market transformation Tianyikang has been continuous innovation, some are research and development technology and even subversive, some belong to the management model of micro-innovation Each year, according to the state of enterprise development, Tianyikang will determine a theme, around such a spirit to develop the annual work objectives and achieve it Tian-Jiang Yikang researchers focus on research and development mind-set focus on products is the key word of Tian-Jiang Yikang's development in 2014 2014 is a very critical year for TianyiKang, but also a year to build and launch the brand As an entrepreneurial and innovative enterprise, the product is the brand and the market's first shot, Tianyikang with vivid cases to prove to us that the development of enterprises always have to rely on innovative products Only do a product and make features to form a brand, focus on making Tianyi Kang quickly obtained a good brand effect In addition to product research and innovation, borrowing is also an important way for enterprises to expand their influence rapidly Tianyan Yikang set up a more powerful research and development platform, market structure and channels, the introduction of better products and technology, graftmore more excellent human resources, continue to introduce external experts and scholars, looking for professional areas of very outstanding talent, invited top international and domestic experts as advisory panels, and effectively docking the capital market, in the rapid growth process to form a strong boost In order to better realize the complementary advantages, Tianlian Yikang and Anxin Qianhong, high-tech venture capital have reached a strategic cooperation, further consolidate its market position In the brand after the establishment of the stage of deep development, this period is also a real test of the enterprise more important period, only long-term planning and vision of the drive, in order to make enterprises in the market dividend will not lose their way As an innovative biopharmaceutical company with rapid growth to 10 million levels in 3 years, Tianfang Yikang is facing an important stage of deep development into the industry, Tianfang Yikang has formulated three major forward goals for this purpose: First, adhere to the strong development of Tianfang towards the field of biomedicine, grasp the global integration of economic opportunities, for biomedical innovation, green The characteristics of combining the development of the pharmaceutical and innovative industries with intelligent financial innovation seek new opportunities and new models for enterprises in the field of international cooperation, second, optimize their own industrial chain configuration in the field of biomedicine, realize the innovation industry cluster and innovation industry chain which are in harmony with international development, and develop the international advanced biopharmaceutical technology innovation system, and the innovative pharmaceutical products with independent intellectual property rights have been breakthrough and widely used Tianyikang Research Laboratory